(Q73370072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

[Rheumatoid arthritis: new molecular and cellular aspects] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Distler O

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Müller-Ladner U

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Schölmerich J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gay RE

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gay S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

673-680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

3 November 2019

cites work

1 reference

12 December 2020

Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10

1 reference

12 December 2020

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

12 December 2020

Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice

1 reference

12 December 2020

Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro.

1 reference

12 December 2020

Expression of E-selectin messenger RNA and protein in rheumatoid arthritis

1 reference

12 December 2020

Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry

1 reference

12 December 2020

Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium

1 reference

12 December 2020

Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin

1 reference

12 December 2020

In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium

1 reference

12 December 2020

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

1 reference

12 December 2020

Fibronectin synthesis in superficial and deep layers of normal articular cartilage

1 reference

12 December 2020

Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.

1 reference

12 December 2020

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis.

1 reference

12 December 2020

Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis

1 reference

12 December 2020

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

12 December 2020

Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus.

1 reference

12 December 2020

Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model

1 reference

12 December 2020

Expression of Adhesion Molecules in Early Rheumatoid Synovial Tissue

1 reference

12 December 2020

Novel strategies for the therapy of rheumatoid arthritis

1 reference

12 December 2020

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis

1 reference

12 December 2020

Oncogenes in rheumatoid arthritis.

1 reference

12 December 2020

Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium

1 reference

12 December 2020

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

12 December 2020

Pathways to gene therapy in rheumatoid arthritis

1 reference

12 December 2020

Oncogene activation in rheumatoid synovium

1 reference

12 December 2020

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 beta

1 reference

12 December 2020

Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts

1 reference

12 December 2020

Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium

1 reference

12 December 2020

Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer

1 reference

12 December 2020

Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium

1 reference

12 December 2020

Ras activation of genes: Mob-1 as a model

1 reference

12 December 2020

Fas antigen expression on synovial cells was down-regulated by interleukin 1 beta

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Histomorphological basis of articular cartilage destruction in rheumatoid arthritis

1 reference

12 December 2020

Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.

1 reference

12 December 2020

The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis

1 reference

12 December 2020

Gene therapy in osteoarticular diseases: where are we?

1 reference

12 December 2020

Type VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial fibroblasts and is suppressed by interleukin-1

1 reference

12 December 2020

Interleukin-1 receptor antagonist

1 reference

12 December 2020

Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis

1 reference

12 December 2020

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis

1 reference

12 December 2020

How important are T cells in chronic rheumatoid synovitis?

1 reference

12 December 2020

TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.

1 reference

12 December 2020

H-ras oncogene point mutations in arthritic synovium

1 reference

12 December 2020

Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03044757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10641509%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference